跳至主要内容
临床试验/NCT02673203
NCT02673203已完成不适用

Investigation Into the Effects of Blood Glucose Levels Upon Eating Behavior in Lean and Obese Non-diabetic and Diabetic Subjects

Yale University2 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2016年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
31
试验地点
2
主要终点
Rate of Changing Glucose Level

研究概览

简要总结

To investigate whether the daily glucose profiles as assessed by continuous glucose monitoring for 1 week of normal weight and obese individuals relate to hunger levels and food intake.

详细描述

To evaluate the effect of blood glucose levels on eating behavior in a population of patients with diabetes in a free-living environment; the investigators plan to study lean healthy control subjects (BMI <25 kg/m2) and obese non-diabetic subjects (BMI > 30 kg/m2).

The participants who qualify will be invited to use the CGMS (DEXCOM G4 Platinum) for up to 7 days. On the visit for placement of the CGMS: 1) the participants will be explained by one of the study physicians how to use a glucometer (FreeStyle or Accu-Check), 2) they will have the CGMS inserted under the skin, and 3) they will be instructed how to fill up the food log (informational brochures are available at the end of the protocol. On the second visit (up to 7 days after the initial visit) the CGMS will be removed from the skin and the glucose meter and food log will be returned to the investigators.

When this study was initially designed, it incorporated 2 additional arms in the study: T1DM and obese T2DM patients. These patients were never recruited for the study.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •A1c < 10.5 %

排除标准

  • •BMI <18 (no upper limit),
  • •Creatinine > 1.5 mg/dL,
  • •Hgb < 10 mg/dL,
  • •ALT > 2.5 X ULN,
  • •untreated thyroid disease,
  • •uncontrolled hypertension,
  • •known neurological disorders,
  • •untreated psychiatric disorders,
  • •use of antidepressants and psychiatric medications,
  • •use of weight loss medications in the 6 months prior to the study,
  • •malignancy,
  • •current or recent steroid use in last 3 months,
  • •history of current illicit drug use;
  • •for women: pregnancy, or breastfeeding.

研究组 & 干预措施

Lean Healthy Control

Active Comparator

(BMI <25 kg/m2)

干预措施: Continuous Glucose Monitoring System (CGMS) (Device)

Lean Healthy Control

Active Comparator

(BMI <25 kg/m2)

干预措施: Food log (Behavioral)

Obese non-diabetic subject

Active Comparator

BMI > 30 kg/m2

干预措施: Continuous Glucose Monitoring System (CGMS) (Device)

Obese non-diabetic subject

Active Comparator

BMI > 30 kg/m2

干预措施: Food log (Behavioral)

结局指标

主要结局

Rate of Changing Glucose Level

时间窗: 3-5 days

The CGM sensor measures the glucose levels from the interstitial tissue. Presented is the rate of changing glucose level (mg/dl/min).

Glucose Peak

时间窗: 3-5 days

The CGM sensor measures the glucose levels from the interstitial tissue. Presented is the glucose peak (mg/dl).

Glucose Nadir

时间窗: 3-5 days

The CGM sensor measures the glucose levels from the interstitial tissue. Presented is the glucose nadir (mg/dl).

次要结局

  • Difference in Glucose Peak and Nadir(3-5 days)
  • Average Daily Hunger Rating(3-5 days)
  • Nutirion Intake: Energy(3-5 days)
  • Nutirion Intake: Carbohydrate(3-5 days)
  • Nutirion Intake: Fat(3-5 days)
  • Nutirion Intake: Protein(3-5 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验